EU regulator approves Pfizer vaccine for children aged 5-11 – RT World News

The European Medicines Agency (EMA) on Thursday approved the use of the Pfizer COVID vaccine on children aged 5- to 11 years, the first time the EU regulator has approved a COVID jab for use in young children.

In a statement issued by the EMA, the drug regulator said that it has “Recommended to extend the indication for [Pfizer] The covid-19 vaccine community to include use in children aged five to 11 years. ,

It is the first time an EU regulator has given the green light to a Covid jab for this age group, allowing governments across Europe to begin vaccinating millions of school children, as the nation grapples with the effects of a new spread of the infection on the continent. want to limit. ,

Prior to the EMA’s decision, several countries have directed their national drug regulators to explore giving Pfizer vaccines to children under the age of five. French Health Minister Olivier Veran has asked the country’s Medical Ethics Committee to explore the extent of the rollout, while Ireland’s Taoiseach Michel Martin disagreed with the country’s advisory committee, saying the government was ready and willing to vaccinate children. is waiting.

EMA’s decision comes after Pfizer and BioNTech submitted a request to EMA to expand the delivery of their mRNA jab to young children, which conducted a study in September showing a stronger immunity in 5- to 11-year-olds. The response was shown.

While some countries await the EMA’s approval and a decision from their national regulator, Austria has already begun vaccinating young children amid a spike in COVID cases, prompting the country to return to a national lockdown. force to.

Pfizer’s ability to roll out the vaccine for young children follows a warning from the World Health Organization (WHO) that more than 2 million people could die from Covid across Europe during the winter.

Think your friends would be interested? Share this story!

Author: admin

Leave a Reply

Your email address will not be published. Required fields are marked *